| View |
|
DR-XY27020
|
Guaifenesin + Salbutamol
|
Salvex XP
|
100 mg/2 mg
|
Film-Coated Tablet
|
Expectorant/Beta-2-Adrenoreceptor Agonist
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
09 June 2021
|
13 June 2026
|
| View |
|
DR-XY27030
|
Adapalene
|
Differin
|
0.1% (1mg/g)
|
Cream
|
-
|
Laboratories Galderma
|
France
|
-
|
30 July 2020
|
06 December 2025
|
| View |
|
DR-XY27057
|
Chlorphenamine Maleate
|
Valemine
|
2 mg/5 mL
|
Syrup
|
Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
24 June 2021
|
05 July 2026
|
| View |
|
DR-XY27059
|
Phenylpropanolamine Hydrochloride/Brompheniramine Maleate
|
Nostero
|
12.5 mg/4 mg per 5 mL
|
Syrup
|
Decongestant / Anthistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
25 June 2021
|
09 July 2026
|
| View |
|
DR-XY27060
|
Clotrimazole
|
Candid-V6
|
100 mg
|
Vaginal Insert
|
Antifungal (Imidazole)
|
Glenmark Pharmaceuticals Ltd.
|
India
|
Renewal
|
02 July 2024
|
13 June 2028
|
| View |
|
DR-XY27068
|
Hypromellose
|
Genteal
|
3 mg/mL (0.3%)
|
Ophthalmic Drops
|
Lubricant
|
Excel Vision
|
France
|
Automatic Renewal (OTC)
|
30 March 2021
|
24 July 2026
|
| View |
DR-XY27080_PI_01-NO RX SYMBOL.pdf
|
DR-XY27080
|
Ketorolac trometamol
|
Acular
|
5mg/mL (0.5% w/v)
|
Sterile Ophthalmic Solution
|
Anti inflammatory Agent, Non-Steroid
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Renewal
|
27 March 2024
|
02 August 2029
|
| View |
DR-XY27082_PI_01.pdf
|
DR-XY27082
|
Esomeprazole (As Magnesium Trihydrate)
|
Nexium®
|
20 mg
|
Enteric-Coated Tablet
|
-
|
AztraZeneca AB
|
Sweden
|
-
|
03 August 2020
|
06 December 2025
|
| View |
|
DR-XY27088
|
Calcium Carbonate + Cholecalciferol (Vitamin D3) + Simethicone
|
Esvical Forte
|
750mg/ 10 IU/ 10mg
|
Chewable Tablet
|
Mineral / Antacid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
31 July 2021
|
06 August 2026
|
| View |
|
DR-XY27090
|
Pentoxifylline
|
Pentox 400
|
400 mg
|
Extended-Release Tablet
|
-
|
Yu Sheng Pharmaceutical Co.
|
Taiwan
|
Automatic Renewal
|
23 June 2021
|
14 August 2026
|
| View |
|
DR-XY27095
|
Cefradine
|
Zepdril
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporins)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 April 2022
|
17 August 2026
|
| View |
|
DR-XY27113
|
Amoxicillin (as Trihydrate)
|
Moks
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
27 May 2024
|
23 August 2029
|
| View |
|
DR-XY27120
|
Losartan Potassium + Hydrochlorothiazide
|
Hyzaar Ds
|
100/25mg
|
Tablet
|
-
|
Merck Manufacturing Division-Cramlington
|
United Kingdom
|
-
|
20 April 2020
|
30 May 2025
|
| View |
|
DR-XY27128
|
Phenylpropanolamine Hydrochloride/Brompheniramine Maleate
|
Nostero
|
6.25 mg /2 mg per mL
|
Syrup (Drops)
|
Decongestant / Anthistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
25 June 2021
|
07 September 2026
|
| View |
|
DR-XY27129
|
PHENYLPROPANOLAMINE HYDROCHLORIDE + BROMPHENIRAMINE MALEATE
|
Eldrex
|
6.25mg/2mg per mL
|
Syrup (Oral Drops)
|
Decongestant/Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 September 2021
|
07 September 2026
|
| View |
|
DR-XY27137
|
Ceftriaxone (as Sodium)
|
Keptrix
|
1g
|
Powder for Injection (IM/IV)
|
Antibacterials
|
Biolab Co., Ltd.
|
Thailand
|
Automatic Renewal
|
14 July 2021
|
13 September 2026
|
| View |
|
DR-XY27140
|
Ambroxol Hydrochloride
|
Broxoflem
|
6mg/ mL
|
Syrup (Oral Drops)
|
Mucolytic
|
Diamond Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 August 2021
|
21 September 2026
|
| View |
|
DR-XY27147
|
Phenylpropanolamine Hydrochloride+Brompheniramine Maleate
|
Nasatapp
|
15 mg/12 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
15 January 2021
|
26 September 2026
|
| View |
|
DR-XY27158
|
Dexamethasone (As Sodium Phosphate)
|
Dexticort
|
4mg/mL
|
Solution For Injection (IM/IV)
|
Corticosteroid
|
L.B.S. Laboratory Limited Partnership
|
Thailand
|
Automatic Renewal
|
08 July 2021
|
18 August 2026
|
| View |
|
DR-XY27180
|
Nifedipine
|
Adalat GITS 60
|
60mg
|
Prolonged-Release Tablet
|
: Calcium Channel Blocker
|
Bayer Pharma AG
|
Germany
|
Automatic Renewal
|
31 August 2021
|
06 August 2026
|